Oeller, Marc http://orcid.org/0000-0003-0597-5950
Kang, Ryan J. D. http://orcid.org/0009-0003-4487-2628
Bolt, Hannah L. http://orcid.org/0000-0002-4106-8912
Gomes dos Santos, Ana L. http://orcid.org/0000-0003-4618-1583
Weinmann, Annika Langborg http://orcid.org/0009-0003-5085-1583
Nikitidis, Antonios
Zlatoidsky, Pavol
Su, Wu http://orcid.org/0000-0003-0785-794X
Czechtizky, Werngard
De Maria, Leonardo http://orcid.org/0000-0002-8061-4242
Sormanni, Pietro http://orcid.org/0000-0002-6228-2221
Vendruscolo, Michele http://orcid.org/0000-0002-3616-1610
Article History
Received: 6 March 2023
Accepted: 26 October 2023
First Online: 17 November 2023
Competing interests
: The authors declare the following competing financial interest(s): H.L.B., A.L.G.d.S., A.L., A.N., P.Z., W.S., L.D.M, and W.C. are employees of AstraZeneca and may own stocks or stock options. The remaining authors declare no competing interests.